Public Health | May 07, 2026
Experts call for easing access to 2mg and 4mg nicotine replacement therapies
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The standout story remains Wegovy, particularly its new oral formulation
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
AI-enabled technology platform delivers integrated pharmacovigilance solutions with measurable efficiency gains and enhanced compliance
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Subscribe To Our Newsletter & Stay Updated
